BB-101 passed Phase I clinical trials by the US FDA, eliminating risks of urinary flatworm infections during treatment.
https://blueblood.com.tw/wp-content/uploads/2024/09/3d-render-medical-background-with-dna-strands-connecting-dots-拷貝.jpg8001200agent30/wp-content/uploads/2025/03/logo-color.pngagent302016-07-01 12:00:572025-06-27 09:55:59BB-101 passed Phase I clinical trials by the US FDA, eliminating risks of urinary flatworm infections during treatment.
